Adjuvant Chemotherapy for High-Risk Stage II Colon Cancer: A Population-Based Study

被引：0
|
作者：
Annmarie Butare [1 ]
Tia Sutton [1 ]
Elizabeth Kantzler [1 ]
Katie N. Kennedy [2 ]
Dmitry Tumin [3 ]
Michael D. Honaker [4 ]
机构：
[1] Carolina University,Department of Surgery, Brody School of Medicine at East
[2] Brody School of Medicine at East Carolina University,Department of Hematology and Oncology
[3] East Carolina University Brody School of Medicine,Department of Academic Affairs
[4] East Carolina University,Department of Surgery, Division of Surgical Oncology, Division of Surgical Oncology
来源：
Journal of Gastrointestinal Cancer | 2025年 / 56卷 / 1期
关键词：
Adjuvant chemotherapy; Stage II colon cancer; High risk;
D O I：
10.1007/s12029-025-01186-z
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Use of adjuvant chemotherapy in patients with stage III colon cancer in Puerto Rico: A population-based study
    Ortiz-Ortiz, Karen J.
    Tortolero-Luna, Guillermo
    Rios-Motta, Ruth
    Veintidos-Feli, Alejandro
    Hunter-Mellado, Robert
    Torres-Cintron, Carlos R.
    Suarez-Ramos, Tonatiuh
    Magno, Priscilla
    PLOS ONE, 2018, 13 (03):
  • [32] Patterns of Adjuvant Chemotherapy Use in a Population-Based Cohort of Patients With Resected Stage II or III Colon Cancer
    Abrams, Thomas A.
    Brightly, Rick
    Mao, Jianbin
    Kirkner, Gregory
    Meyerhardt, Jeffrey A.
    Schrag, Deborah
    Fuchs, Charles S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (24) : 3255 - 3262
  • [33] High Expression of CUL9 Is Prognostic and Predictive for Adjuvant Chemotherapy in High-Risk Stage II and Stage III Colon Cancer
    Zheng, Peng
    Lv, Yang
    Mao, Yihao
    Shen, Feifan
    Zhang, Zhiyuan
    Chang, Jiang
    Yu, Shanchao
    Ji, Meiling
    Feng, Qingyang
    Xu, Jianmin
    CANCERS, 2022, 14 (16)
  • [34] ADJUVANT CHEMOTHERAPY USE FOR STAGE II COLON CANCER IN MEDICARE POPULATION
    Jiao, X.
    Zhang, H.
    Barzi, A.
    VALUE IN HEALTH, 2018, 21 : S44 - S44
  • [35] Adjuvant Chemotherapy for Stage II Colon Cancer
    Rebuzzi, Sara Elena
    Pesola, Guido
    Martelli, Valentino
    Sobrero, Alberto Felice
    CANCERS, 2020, 12 (09) : 1 - 12
  • [36] Impact of Adjuvant Chemotherapy on Recurrence Risk in Stage II Colon Cancer
    Adesoye, T.
    Hu, C.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : S91 - S91
  • [37] Patient Selection for Adjuvant Chemotherapy in High-Risk Stage II Colon Cancer A Systematic Review and Meta-Analysis
    Zhang, Chao
    Yin, Songcheng
    Tan, Yuen
    Huang, Jinyu
    Wang, Pengliang
    Hou, Wenbin
    Zhang, Zhe
    Xu, Huimian
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2020, 43 (04): : 279 - 287
  • [38] Duration of FOLFOX adjuvant chemotherapy in high-risk stage II and stage III colon cancer with deficient DNA mismatch repair.
    Wu, Zehua
    Hu, Huabin
    Wang, Chao
    Huang, Yan
    Deng, Yanhong
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [39] Cost-effectiveness of adjuvant chemotherapy for patients with high-risk stage II and stage III colon cancer in South Africa.
    Pumpalova, Yoanna S.
    Rogers, Alexandra M.
    Tan, Sarah Xinhui
    Herbst, Candice-Lee
    Ruff, Paul
    Neugut, Alfred I.
    Hur, Chin
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [40] Effect of Adjuvant Chemotherapy on Elderly Stage II High-Risk Colorectal Cancer Patients
    Lee, Yujin
    Park, Inseok
    Cho, Hyunjin
    Gwak, Geumhee
    Yang, Keunho
    Bae, Byung-Noe
    ANNALS OF COLOPROCTOLOGY, 2021, 37 (05) : 298 - 305
12345